Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Net Income (2019 - 2025)

Historic Net Income for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $67.1 million.

  • Strata Critical Medical's Net Income rose 172610.94% to $67.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.3 million, marking a year-over-year increase of 19003.45%. This contributed to the annual value of -$27.3 million for FY2024, which is 5130.36% up from last year.
  • Strata Critical Medical's Net Income amounted to $67.1 million in Q3 2025, which was up 172610.94% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Net Income registered a high of $67.1 million during Q3 2025, and its lowest value of -$33.9 million during Q4 2023.
  • In the last 5 years, Strata Critical Medical's Net Income had a median value of -$7.8 million in 2021 and averaged -$3.7 million.
  • As far as peak fluctuations go, Strata Critical Medical's Net Income plummeted by 12980638.58% in 2021, and later surged by 172610.94% in 2025.
  • Strata Critical Medical's Net Income (Quarter) stood at $772000.0 in 2021, then crashed by 2096.76% to -$15.4 million in 2022, then plummeted by 120.18% to -$33.9 million in 2023, then surged by 45.27% to -$18.6 million in 2024, then soared by 461.07% to $67.1 million in 2025.
  • Its last three reported values are $67.1 million in Q3 2025, -$3.7 million for Q2 2025, and -$3.5 million during Q1 2025.